Tender detail

Non-exclusive discount agreement for medicines containing ezetimibe and atorvastatin

Summary

DAK-Gesundheit intends to conclude medicine discount agreements for products containing the active substances ezetimibe and atorvastatin (ATC C10BA05), excluding packs of 88 units. The agreement takes effect on 1 December 2026 and runs until 30 November 2028, with one possible 12-month extension. It ends automatically when an exclusive agreement takes effect.

Reference number
6f811c76-e441-4205-9dfe-61573a09c08f
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2029-10-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.